These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 11809111

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [The toxic effects of high-dose Bcl-2 antisense phosphorothioate oligodeoxynucleotides incubation on cell line].
    Lin Y, Lü L, Chen Z.
    Zhonghua Yi Xue Za Zhi; 2000 Sep; 80(9):694-7. PubMed ID: 11798838
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM, Fang DC, Yang JL, Chen L, Luo YH, Liang GP.
    Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Bcl-2 antisense oligodeoxynucleotide therapy of Epstein-Barr virus-associated lymphoproliferative disease in severe combined immunodeficient mice.
    Guinness ME, Kenney JL, Reiss M, Lacy J.
    Cancer Res; 2000 Oct 01; 60(19):5354-8. PubMed ID: 11034070
    [Abstract] [Full Text] [Related]

  • 28. [Apoptotic effect of bcl-XL antisense oligodeoxynucleotide mediated by lipofectin on cell strain CNE-2Z].
    He GR, Zhou KY, Cai KR, Liang T, He CW, Zhang YF.
    Ai Zheng; 2003 Jan 01; 22(1):11-5. PubMed ID: 12561428
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. C-Met antisense oligodeoxynucleotide inhibits growth of glioma cells.
    Chu S, Yuan X, Li Z, Jiang P, Zhang J.
    Surg Neurol; 2006 Jun 01; 65(6):533-8; discussion 538. PubMed ID: 16720163
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Modulation of apoptosis, tumorigenesity and metastatic potential with antisense H-ras oligodeoxynucleotides in a high metastatic tumor model of hepatoma: LCI-D20.
    Liao Y, Tang ZY, Ye SL, Liu KD, Sun FX, Huang Z.
    Hepatogastroenterology; 2000 Jun 01; 47(32):365-70. PubMed ID: 10791191
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pituitary tumor-transforming gene (PTTG): a novel target for anti-tumor therapy.
    Solbach C, Roller M, Peters S, Nicoletti M, Kaufmann M, Knecht R.
    Anticancer Res; 2005 Jun 01; 25(1A):121-5. PubMed ID: 15816528
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Effects of STAT3 antisense oligodeoxynucleotides on apoptosis and proliferation of mouse melanoma cell line B16].
    Tang GS, Cai JM, Ni J, Xiang YS, Cui JG, Zhu D, Dong JR.
    Ai Zheng; 2006 Mar 01; 25(3):269-74. PubMed ID: 16536977
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.